Asphalion at EU pharma regulatory environment seminar from EUCRAF

EUCRAF provides the opportunity of a specialized education in the area of biopharmaceutical-related regulatory affairs

EUCRAF provides the opportunity of a specialized education in the area of biopharmaceutical-related regulatory affairs
September 16, 2015
Lidia Cánovas and Dominique Monferrer from Asphalion will be speakers at European pharmaceutical regulatory environment seminar from EUCRAF.
EUCRAF provides the opportunity of a specialized education in the area of biopharmaceutical-related regulatory affairs. This seminar is a part of the Postgraduate Certificate as “Regulatory Affairs Manager” based on 6 seminars and a part of the Master degree based on 10 seminars. This allows adapting the program to everyone specific needs.
The subject area Regulatory Affairs ensures that the proof of the quality, safety and efficacy of the medicinal product is demonstrated to be in line with legal requirements for the purposes of marketing safe and efficacious medicinal products solely in the interests of public health.
These are the topics to be discussed during the seminar:
  • The European Pharmaceutical Legislation
  • The regulatory institutions and other stakeholders
  • Interaction of international regulatory agencies
  • General requirements for the Common Technical Document (CTD), the Marketing Authorisation Dossier Modules 1 and SmPC, Module 2, Risk Management Plan
  • Special legal provisions for biopharmaceuticals
  • Orphan Drug Designation – provisions and procedures
  • SME – provisions and procedures
  • Principles of registration and certification of medical devices and device/drug combinations.
EUCRAF is the acronym of European Centre for Regulatory Affairs. It is an independent organization dedicated to deliver up-to-date training program on regulatory affairs and drug development, with a focus on biopharmaceutical-related regulatory affairs in Europe. The program also covers the essential details for the systems in the US, Japan, Switzerland and other regions such as China.
Founded in 2009, EUCRAF was conceived because there was a lack of an adequate training platform specifically on biopharmaceutical-related regulatory affairs and drug development. Based on an intensive dialogue with key stakeholders from authorities, universities and industry, a specialized program on biopharmaceuticals related regulatory affairs and drug development was developed for the first time in Europe.
Lídia Cánovas
Lidia Cánovas has a degree in Pharmacy from the University of Barcelona and is currently the General Manager – Commercial of Asphalion, S.L., consultancy company to which she associated in 2003.

Her main activities focus on consulting and strategic direction of projects in the area of Regulatory Affairs and Development for Europe and USA, actively participating in scientific advice, Paediatric Plans, Orphan Drug Designations, Development Plans, Centralized procedures, decentralized and mutual recognition in permanent contact with the regulatory authorities. She also has extensive regulatory experience in innovative, biological, biotech and advanced therapy.
She previously held positions in the pharmaceutical industry as Director of Regulatory Affairs, Vice-Director of R&D and Technical Director (Qualified Person).
Topic lectured:
Seminar 1:
Format and content of the marketing authorisation application: The Common Technical Dossier (CTD)
Module 1 of the CTD: General information
Labeling, Package Leaflet and Summary of Product Characteristics (SmPC)

Dominique Monferrer
Dr. Dominique Monferrer holds a degree in Human Biology and a PhD in X-ray Macromolecular Crystallography. She worked for several years as a researcher at molecular laboratory institutions and synchrotrons in Spain and Germany before joining Asphalion as regulatory affairs consultant.
As regulatory affairs manager, her main areas of expertise include providing scientific assessment in development of chemical drugs and biologics (including biosimilars and cell-therapy medicinal products), carrying out and overseeing CMC and medical writing of regulatory documentation (e.g. IMPDs, scientific advice briefing packages, registration dossiers, etc.), as well as conducting viability analyses and designing tailored roadpmaps for innovative medical devices and in-vitro diagnostics.Topic lectured:
Seminar 1:
Format and Content of the MAA Dossier: CTD and eCTD

Search News & Events

  • Filter by category


Related news and events

Christmas season greatings

Season’s Greetings

We wish you Happy ‘Xmas, Prosperous New Year and Health for you and your loved ones.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting